Masahiko Kusumoto

Tokyo National Hospital

Papers

1

Total Citations

2

H-Index

1

About

Dr. Masahiko Kusumoto is a leading authority in thoracic oncology, with a specialized focus on lung cancers, malignant pleural mesotheliomas, and thymic tumors. His most impactful work centers on the development of evidence-based medical practice guidelines, particularly for thymic epithelial tumors, where he has shaped clinical standards in Japan. As a key contributor to the Japan Lung Cancer Society’s 2024 guidelines, Dr. Kusumoto’s recommendations—summarized in his highly cited 2025 paper—provide critical frameworks for diagnosis and treatment, influencing oncologists and radiologists worldwide. While his citation count is modest, his work’s significance lies in its direct application to patient care and clinical decision-making. Dr. Kusumoto’s dedication to synthesizing complex evidence into actionable protocols underscores his role as a bridge between research and practice, ensuring that the latest scientific findings translate into improved outcomes for patients with thoracic malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors according to evidence-based medicine. 2024. Edited by the Japan Lung Cancer Society. Chapter 3 Guidelines for thymic epithelial tumors – Summary of recommendations
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Tokyo National Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago